Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia - PubMed (original) (raw)
Comparative Study
doi: 10.1016/j.cancergencyto.2003.12.011.
Anna Aventín, Francisca Fuentes, Teresa Vallespí, Isabel Granada, Anna Carrió, José Angel Martínez-Climent, Francesc Solé, Montserrat Teixidó, Marta Bernués, José Duarte, Jesús Maria Hernández, Salut Brunet, Maria Dolors Coll, Jorge Sierra
Affiliations
- PMID: 15325089
- DOI: 10.1016/j.cancergencyto.2003.12.011
Comparative Study
Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia
Sílvia Casas et al. Cancer Genet Cytogenet. 2004 Aug.
Abstract
A total of 127 adult de novo acute myelocytic leukemia (AML) patients were analyzed by comparative genomic hybridization (CGH) at diagnosis. Conventional cytogenetic analysis (CCA) showed a normal karyotype in 45 cases and an abnormal karyotype in 56 cases; in the remaining cases, CCA either failed to yield sufficient metaphase cells (19/26) or was not done (7/26). Abnormal CGH profiles were identified in 39 patients (30.7%). DNA copy number losses (61%) were high compared to gains (39%), whereas partial chromosome changes (76%) were more common than whole chromosomes changes (24%). Recurrent losses were detected on chromosomes 7, 5q (comprising bands 5q15 to 5q33), 7q (7q32 approximately q36), 16q (16q13 approximately q21), and 17p, and gains were detected on chromosomes 8, 22, and 3q (comprising bands 3q26.1 approximately q27). Furthermore, distinct amplifications were identified in chromosome regions 21q, 13q12 approximately q13, and 13q21.1. No cryptic recurrent chromosomal imbalances were identified by CGH in cases with normal karyotypes. The concordance between CGH results and CCA was 72.5%. In the remaining cases, CGH gave additional information compared to CCA (20%) and partially failed to identify the alterations previously detected by CCA (7.5%). The majority of discrepancies arose from the limitations of the CGH technique, such as insensitivity to detect unbalanced chromosomal changes when occurring in a low proportion of cells. CGH increased the detection of unbalanced chromosomal alterations and allowed precise defining of partial or uncharacterized cytogenetical abnormalities. Application of the CGH technique is thus a useful complementary diagnostic tool for CCA in de novo AML cases with abnormal karyotypes or with unsuccessful cytogenetics.
Similar articles
- Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W, Li JY, Liu Q, Zhu Y, Pan JL, Qiu HR, Xue YQ. Xu W, et al. Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e86-95. doi: 10.1111/j.1751-553X.2008.01101.x. Epub 2008 Oct 13. Int J Lab Hematol. 2010. PMID: 20089000 - Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C, Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR, Lichter P, Döhner K, Döhner H. Rücker FG, et al. J Clin Oncol. 2006 Aug 20;24(24):3887-94. doi: 10.1200/JCO.2005.04.5450. Epub 2006 Jul 24. J Clin Oncol. 2006. PMID: 16864856 - Efficacy of high-resolution comparative genomic hybridization (HR-CGH) in detection of chromosomal abnormalities in children with acute leukaemia.
Vranova V, Mentzlova D, Oltova A, Linkova V, Zezulkova D, Filkova H, Mendelova D, Sterba J, Kuglik P. Vranova V, et al. Neoplasma. 2008;55(1):23-30. Neoplasma. 2008. PMID: 18190236 - DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes.
Suela J, Alvarez S, Cigudosa JC. Suela J, et al. Cytogenet Genome Res. 2007;118(2-4):304-9. doi: 10.1159/000108314. Cytogenet Genome Res. 2007. PMID: 18000384 Review. - Characterisation of hairy cell leukaemia by tiling resolution array-based comparative genome hybridisation: a series of 13 cases and review of the literature.
Nordgren A, Corcoran M, Sääf A, Bremer A, Kluin-Nelemans HC, Schoumans J, Grandér D. Nordgren A, et al. Eur J Haematol. 2010 Jan 1;84(1):17-25. doi: 10.1111/j.1600-0609.2009.01334.x. Eur J Haematol. 2010. PMID: 19682064 Review.
Cited by
- Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.
Mareschal S, Palau A, Lindberg J, Ruminy P, Nilsson C, Bengtzén S, Engvall M, Eriksson A, Neddermeyer A, Marchand V, Jansson M, Björklund M, Jardin F, Rantalainen M, Lennartsson A, Cavelier L, Grönberg H, Lehmann S. Mareschal S, et al. Blood Adv. 2021 Feb 23;5(4):1003-1016. doi: 10.1182/bloodadvances.2020002517. Blood Adv. 2021. PMID: 33591326 Free PMC article. - Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
Zhang R, Kim YM, Wang X, Li Y, Lu X, Sternenberger AR, Li S, Lee JY. Zhang R, et al. Int J Med Sci. 2015 Sep 1;12(9):719-26. doi: 10.7150/ijms.12612. eCollection 2015. Int J Med Sci. 2015. PMID: 26392809 Free PMC article. - Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS, Vassiliou GS. Grove CS, et al. Dis Model Mech. 2014 Aug;7(8):941-51. doi: 10.1242/dmm.015974. Dis Model Mech. 2014. PMID: 25056697 Free PMC article. Review. - Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization.
Mehrotra M, Luthra R, Ravandi F, Sargent RL, Barkoh BA, Abraham R, Mishra BM, Medeiros LJ, Patel KP. Mehrotra M, et al. Leuk Lymphoma. 2014 Nov;55(11):2538-48. doi: 10.3109/10428194.2014.883073. Leuk Lymphoma. 2014. PMID: 24446873 Free PMC article. - The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?
Vilborg A, Bersani C, Wilhelm MT, Wiman KG. Vilborg A, et al. Cell Death Differ. 2011 Sep;18(9):1434-40. doi: 10.1038/cdd.2011.20. Epub 2011 Mar 11. Cell Death Differ. 2011. PMID: 21394102 Free PMC article. Review.